SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma | |
Qin, Yu; Bao, Huijing; Pan, Yi; Yin, Meilin; Liu, Yunde; Wu, Shangwei; Li, Huikai | |
2014 | |
卷号 | 9期号:3页码:877-881 |
关键词 | SUMOylation hepatocellular carcinoma multidrug resistance ubiquitin-like modifier activating enzyme 2 sentrin-specific protease 1 |
ISSN号 | 1791-2997 |
DOI | 10.3892/mmr.2014.1882 |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6682770 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Qin, Yu,Bao, Huijing,Pan, Yi,et al. SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma[J],2014,9(3):877-881. |
APA | Qin, Yu.,Bao, Huijing.,Pan, Yi.,Yin, Meilin.,Liu, Yunde.,...&Li, Huikai.(2014).SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma.,9(3),877-881. |
MLA | Qin, Yu,et al."SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma".9.3(2014):877-881. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论